Production (Stage)
Microbot Medical Inc.
MBOT
$2.62
-$0.02-0.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 64.74% | 53.45% | 2.15% | -15.38% | -24.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.57% | 17.96% | -5.45% | -19.33% | -28.44% |
| Operating Income | -31.57% | -17.96% | 5.45% | 19.33% | 28.44% |
| Income Before Tax | -13.79% | -6.55% | -5.87% | 10.08% | 20.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.79% | -6.55% | -5.87% | 10.08% | 20.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.79% | -6.55% | -5.87% | 10.08% | 20.06% |
| EBIT | -31.57% | -17.96% | 5.45% | 19.33% | 28.44% |
| EBITDA | -32.28% | -18.31% | 5.47% | 19.41% | 28.70% |
| EPS Basic | 28.05% | 32.66% | 33.75% | 45.31% | 48.30% |
| Normalized Basic EPS | 18.31% | 26.24% | 41.55% | 51.63% | 53.73% |
| EPS Diluted | 28.05% | 32.91% | 33.97% | 45.45% | 48.42% |
| Normalized Diluted EPS | 18.31% | 26.24% | 41.55% | 51.63% | 53.73% |
| Average Basic Shares Outstanding | 70.06% | 53.49% | 56.17% | 63.72% | 56.29% |
| Average Diluted Shares Outstanding | 70.06% | 53.49% | 56.17% | 63.72% | 56.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |